Dr. Martens plc
DOCS.L · LSE
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | £490,292 | £890,209 | £1,423,712 | £2,388,239 |
| - Cash | £155,900 | £111,100 | £157,500 | £228,000 |
| + Debt | £404,100 | £477,000 | £451,800 | £393,800 |
| Enterprise Value | £738,492 | £1,256,109 | £1,718,012 | £2,554,039 |
| Revenue | £787,600 | £877,100 | £1,000,300 | £908,300 |
| % Growth | -10.2% | -12.3% | 10.1% | – |
| Gross Profit | £511,700 | £575,200 | £618,100 | £578,800 |
| % Margin | 65% | 65.6% | 61.8% | 63.7% |
| EBITDA | £110,500 | £196,300 | £235,000 | £265,100 |
| % Margin | 14% | 22.4% | 23.5% | 29.2% |
| Net Income | £4,500 | £69,200 | £128,900 | £181,200 |
| % Margin | 0.6% | 7.9% | 12.9% | 19.9% |
| EPS Diluted | 0.005 | 0.07 | 0.13 | 0.18 |
| % Growth | -92.9% | -46% | -27.8% | – |
| Operating Cash Flow | £196,300 | £167,900 | £77,300 | £184,400 |
| Capital Expenditures | -£18,700 | -£28,400 | -£51,400 | -£25,000 |
| Free Cash Flow | £177,600 | £139,500 | £25,900 | £159,400 |